Keyword: AbbVie

Markets & Companies

After the Big Covid-19 Storm

19.04.2022 -

What does 2022 hold for the biopharma industry? Which companies can play at the forefront in terms of products as well as business? Covid-19 will continue to be a...


AbbVie Expands Neuroscience Portfolio with Syndesi Purchase

09.03.2022 -

US biopharma AbbVie is to take over Belgian biotech Syndesi Therapeutics, in a move that will expand its neuroscience portfolio. Under the agreed terms, AbbVie will pay...


AbbVie and Regenxbio Link on Eye Diseases

17.09.2021 -

US biopharmas AbbVie and Regenxbio are forming a strategic partnership to develop and commercialize a gene therapy for eye diseases. The transaction is expected to close...


AbbVie to Sell off Allergan Women’s Health Portfolio

22.03.2021 -

US pharma AbbVie has put compatriot Allergan’s women’s health business up for sale. The company is said to be working with Morgan Stanley on an auction process that has...


AbbVie and Caribou in CAR-T Collaboration

18.02.2021 -

US biopharma AbbVie and compatriot biotech Caribou Biosciences have entered into a multi-year collaboration and license agreement to research and develop chimeric antigen...


AbbVie and I-Mab in Cancer Collaboration

11.09.2020 -

US biopharma AbbVie has signed a global collaboration agreement with China’s I-Mab to develop and commercialize lemzoparlimab – also known as TJC4 – an anti-CD47...


AbbVie Agrees Cancer Collaborations

17.06.2020 - US drugmaker AbbVie has signed two separate collaboration agreements, one with Denmark’s Genmab and the other with China’s Jacobio Pharmaceuticals, for developing and...


Shire Passes on Irish Tax Bill to Takeda

17.01.2020 - Japanese drugmaker Takeda is facing a large tax bill from Ireland as an uncalculated repercussion of its acquisition of US-managed, Ireland-domiciled Shire at the end of 2018. Tax...